← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$5.1M

Shares

11,250

Price

$450

Filed

Aug 19

Insider

Name

BONNEY MICHAEL W

Title

CIK

0001219016

Roles

Director

Transaction Details

Transaction Date

2025-08-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,804

Footnotes

This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. | The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee. | The stock option was fully vested as of June 3, 2017.

Filing Info

Accession No.

0001735276-25-000087

Form Type

4

Issuer CIK

0001178670

BONNEY MICHAEL W's History

Date Ticker Type Value
2025-08-18 ALNY M $790K
2025-08-18 ALNY $5.1M
2025-08-18 ALNY M $0
2025-05-15 ALNY M $1.5M
2025-05-15 ALNY $147K
2025-05-15 ALNY $196K
2025-05-15 ALNY $66K
2025-05-15 ALNY $117K
2025-05-15 ALNY $180K
2025-05-15 ALNY $241K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06